secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2024-07-25T23:59:59+00:00
Accession:  0001615219-24-000068
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius Pharmaceuticals files prospectus supplement for up to $335,921 ATM stock offering
--------------------------------------------------------------------------------

- Offering of up to $335,921 in common stock under existing ATM agreement with Ladenburg Thalmann & Co. Inc.
- Prospectus supplement filed on July 25, 2024, under effective registration statement (File No. 333-266589).
- Legal opinion of Hogan Lovells US LLP on share validity attached as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000068/0001615219-24-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000068/flks-20240725.htm
  HTML page:      https://secwatch.observer/filing/0001615219-24-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer